NEWS AND PRESS RELEASES

Protective effect of breastfeeding on childhood obesity risk linked to leptin gene modification

Breastfed children have a lower risk of obesity, which may be linked to reduced expression of the hormone, leptin; according to research presented today at the 58th Annual European Society for Paediatric Endocrinology Meeting. The study reported that genetic modifications known to suppress leptin levels were more common in breastfed babies than formula-fed, and that these differences may play a role in the development of obesity. Understanding the link between genetic modification of leptin and obesity risk could advance strategies to prevent and treat childhood obesity and, its complications, in the future; as prevention is better than cure.

Protective effect of breastfeeding on childhood obesity risk linked to leptin gene modification

Sep 2019

Breastfed children have a lower risk of obesity, which may be linked to reduced expression of the hormone, leptin; according to research presented today at the 58th Annual European Society for Paediatric Endocrinology Meeting. The study reported that genetic modifications known to suppress leptin levels were more common in breastfed babies than formula-fed, and that these differences may play a role in the development of obesity. Understanding the link between genetic modification of leptin and obesity risk could advance strategies to prevent and treat childhood obesity and, its complications, in the future; as prevention is better than cure.

Childhood obesity has become a worldwide epidemic that can lead to the development of serious and debilitating conditions in later life, including heart disease and type 2 diabetes. Around 40-70% of obesity cases are thought to have a genetic component but none of the identified obesity-associated genes fully explain its heritability. Epigenetics is a process that affects how our inherited genes are expressed and is a growing area of medical interest, since it can be shaped by experience and environment throughout life. Leptin is a hormone involved in regulating energy balance and higher levels are associated with obesity. Previous research has indicated that breastfed children have a lower risk of obesity but how this may be related to epigenetic regulation of leptin has not been investigated.

In this study, Dr Omneya Magdy Omar and colleagues at Alexandria University Hospital Children’s Hospital, Egypt, tested for epigenetic modifications to the leptin gene in 50, 6-month old babies, 25 of which were breastfed. Epigenetic modifications that decrease leptin levels were significantly more common in formula-fed babies, and one of these modifications was also associated with higher body weight in the non-breastfed infants.

Dr Omar states, “As we know that these genetic modifications in formula-fed babies reduce leptin levels, which is associated with obesity, these findings suggest that epigenetic mechanisms may play a role in the development of obesity.”

Although Dr Omar, cautions, “Further studies are needed to confirm these findings, we had only 50 study participants that were limited to the local area. Also, we did not measure leptin levels or follow what happens as the babies grow.”

The team plan to conduct larger, multicentre studies assessing the long-term role of genetic and environmental factors on epigenetic regulation of leptin, to put these data into context and explore possible therapeutic interventions that could be developed to prevent and treat childhood obesity.

Dr Omar comments, “Although preliminary, we have shown a possible link between breastfeeding and reduced risk of obesity, and added to the growing body of evidence that breastfeeding is recommended whenever possible."

-----ENDS-----

 

Abstract

Leptin Gene Methylation Status In Egyptian Infants

Omneya Magdy Omar, Mohamed Naguib Massoud, Reham Abo Elwafa, Mary Gerges

Alexandria, University, Egypt

 

Background: Obesity results from interactions between environmental and genetic factors. Despite a relatively high heritability of common, non-syndromic obesity (40–70%), the search for genetic variants contributing to susceptibility has been a challenging task. To date, more than 40 genetic variants have been associated with obesity and fat distribution. However, since these variants do not fully explain the heritability of obesity, other forms of variation, such as epigenetics marks, must be considered. DNA methylation is one of the best-understood epigenetic mechanisms and an important programming mechanism of the genome, in which cells and tissues can adapt to past and present environmental exposures. The methylation of the leptin gene promoter suppresses its expression and decrease in leptin production is highly associated with obesity.

Aim: The study aimed to study the leptin gene methylation status in a six-month-old cohort of Egyptian infants.

Patients and methods: The study was carried on 50 infants, aged 6-month-old, attending the outpatient clinic of Alexandria University Children’s Hospital. All infants joined the study were subjected to full history taking, thorough clinical examination stressing on anthropometric measurement. Peripheral blood samples were taken for genetic analysis to study the methylation status of leptin gene promoter by methylation-specific polymerase chain reaction (MS-PCR) at 31 nt at 51 nt loci.

Results: Out of 50 infants 25 were exclusively breastfed and 25 were artificially fed. A significantly higher percentage of formula-fed infants were methylated in leptin gene promoter at 31 nt locus compared with breastfed infants. Also, at 51nt locus infants with methylated leptin gene had significantly higher weight for length standard deviation score compared to infants with methylated gene.

Conclusion: Leptin gene is unmethylated in breastfed infants compared to formula-fed infants. So epigenetics mechanisms could play a role in the development of obesity. 

 

Notes for editors:

1. The study “Leptin Gene Methylation Status In Egyptian Infants” was presented by Dr Omneya Magdy Omar on Thursday 19 September (abstract 5), at the 58th Annual European Society for Paediatric Endocrinology Meeting in Vienna, Austria.

2. The 58th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2019 Meeting) is held 19-21 September 2019 in Vienna, Austria. The ESPE annual meeting is recognised worldwide as being of high scientific and educational quality.

3. The European Society for Paediatric Endocrinology (ESPE) is a truly international organisation aiming to improve the clinical care of children and adolescents with endocrine conditions, including diabetes, through research and education. www.eurospe.org